SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-027016
Filing Date
2023-08-07
Accepted
2023-08-07 16:15:31
Documents
3
Period of Report
2023-08-07

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 410916
2 proxy_001.jpg GRAPHIC 275117
3 proxy_002.jpg GRAPHIC 345651
  Complete submission text file 0001493152-23-027016.txt   1267287
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35570 | Film No.: 231147806
SIC: 2834 Pharmaceutical Preparations